Latest beta-thalassemia Stories
- Jadenu (deferasirox), a new formulation of Exjade (deferasirox), is the only once-daily oral tablet for iron chelation EAST HANOVER, N.J., March 30, 2015 /PRNewswire/ -- Novartis announced
DALLAS, March 26, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Thalassemia - Pipeline Review, H1 2015" therapeutic market research report of 100 pages with latest updates,
The Georgia Health Policy Center (GHPC) at Georgia State University has received a five-year, $2,669,903 award from the U.S.
RICHMOND, Calif., Feb. 4, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
Hunter's Disease and Hurler's Disease Named as Sangamo's First Proprietary Programs in Lysosomal Storage Disorders RICHMOND, Calif., Jan. 12, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
SAN FRANCISCO, Dec.
Funds Will Support Research Into Safety and Efficacy of Umbilical Cord Stem Cell Transplantations to treat Beta Thalassemia Major NEW YORK, Nov.
--Partnership to Focus on Developing Novel Therapies for Sickle Cell Disease and Beta-Thalassemia-- CAMBRIDGE, Mass. and RICHMOND, Calif., Jan.
RICHMOND, Calif., Jan. 8, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
New research presented today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans uncovers several important insights into the pathophysiology of sickle cell disease and thalassemia that may soon translate into the development of better, more targeted treatments for hundreds of thousands of patients worldwide.
- a slit in a tire to drain away surface water and improve traction.